Fosun Pharmaceutical

Shanghai, China Founded: 1994 • Age: 32 yrs Listed
Research, development, production, and sale of pharmaceuticals are provided.

About Fosun Pharmaceutical

Fosun Pharmaceutical is a publicly listed company based in Shanghai (China) founded in 1994. Research, development, production, and sale of pharmaceuticals are provided. The company has 40,560 employees. Fosun Pharmaceutical has completed 3 acquisitions, including Antejin Biotech, Breas Medical and Yiyanyun Medical Technology. Its website fosunpharma.com draws about 22 thousand monthly visits. Fosun Pharmaceutical offers products and services including Pharmaceuticals and Medical Devices. Its focus areas include Traditional Pharmaceuticals, Generics, Therapeutic Areas and Traditional Medical Devices. Its legal entity is Shanghai Fuxing Medicine (Group) Shareholding Company Limited.

Company details

Fosun Pharmaceutical was founded in 1994 in Shanghai, China, where operations in the pharmaceutical sector are centered. Research, development, production, and sales of pharmaceuticals are conducted globally. In 2021, annual revenues of 6.03B were achieved, alongside a net profit of 0.73B. The company is headquartered in Shanghai and maintains a presence in the healthcare industry through its core activities.

  • Headquarters Shanghai, China
  • Employees 40,560
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website fosunpharma.com
  • Social LinkedIn
  • Legal Name Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A
Key Metrics
  • Annual Revenue
    $5.93 B (USD)
    1.44
    as on Dec 31, 2025
  • Net Profit
    $481.36 M (USD)
    21.69
    as on Dec 31, 2025
  • EBITDA
    $871.3 M (USD)
    5.51
    as on Dec 31, 2025
  • Employee Count
    40,560
  • Investments & Acquisitions

Products & Services of Fosun Pharmaceutical

Fosun Pharmaceutical offers a comprehensive portfolio of products and services, including Pharmaceuticals and Medical Devices.

Pharmaceuticals
Healthcare Products

Pharmaceuticals are developed and manufactured for various treatments, focusing on patient needs and clinical demands.

Medical Devices
Medical Equipment

Medical devices and diagnostics are produced and supplied for health services, including tools for diagnosis and treatment.

IPO & Listings of Fosun Pharmaceutical

Fosun Pharmaceutical is a publicly listed company on the SSE with ticker symbol 600196 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date30 Oct 2012
  • Listed onHKG: 2196
  • Listed entityShanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A
  • Exchange sectorHealth technology
  • ISINCNE000000X38
  • Share price23.27 CNY (-1.02% on the day) · 2026-10-14
  • Market capitalisation57,994,469,363.72 CNY
  • Price to earnings18.1
  • EPS (diluted, trailing year)1.28 CNY
  • Dividend yield1.65%
  • Volume (last session)13,536,766

Financials of Fosun Pharmaceutical

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202541.50B CNY3.37B CNY6.10B CNY
202440.92B CNY2.77B CNY5.78B CNY
202341.25B CNY2.39B CNY3.96B CNY
202243.82B CNY3.73B CNY5.57B CNY
202138.87B CNY4.73B CNY4.20B CNY
Premium access

Detailed financial statements for Fosun Pharmaceutical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Fosun Pharmaceutical

Fosun Pharmaceutical has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Antejin Biotech, Breas Medical and Yiyanyun Medical Technology.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Bacterial vaccine development and pharmaceutical services are provided.
Chengdu, China0Nov 2021β€’β€’β€’β€’
Software solutions for pharmacy R&D management are provided.
epharmacloud.comMinhang, China2018Sep 2020$665,316
Sleep therapy and home care ventilation devices
breas.comGothenburg, Sweden1991Mar 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for Fosun Pharmaceutical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Fosun Pharmaceutical

5 dated milestones of Fosun Pharmaceutical across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Fosun Pharmaceutical is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Breas Medical.
  4. Acquisition Acquires Yiyanyun Medical Technology.
  5. Acquisition Acquires Antejin Biotech.

Web traffic of Fosun Pharmaceutical

The website of Fosun Pharmaceutical (fosunpharma.com) receives about 21.9K visits a month.

  • Monthly visits
    21.9K

    ▼ 25.1% vs previous month

Similar websites

Websites whose visitors overlap most with Fosun Pharmaceutical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
tigermed.net
tigermed.net
100%
–
henlius.com
97%
25K#1,127,187View details
bioton.pl
bioton.pl
91%
–
mijian360.com
62%
13.7K#1,976,732View details
ubipharm.com
54%
680.7K#908,789View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for Fosun Pharmaceutical

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fosun Pharmaceutical

Premium access

Complete news archive for Fosun Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fosun Pharmaceutical

Fosun Pharmaceutical was founded in 1994.

Fosun Pharmaceutical is headquartered in Shanghai, China.

Fosun Pharmaceutical has 40,560 employees.

Annual revenue of Fosun Pharmaceutical is $5.93B as on Dec 31, 2025.

Fosun Pharmaceutical was founded in 1994 in Shanghai, China, where operations in the pharmaceutical sector are centered. Research, development, production, and sales of pharmaceuticals are conducted globally. In 2021, annual revenues of 6.03B were achieved, alongside a net profit of 0.73B. The company is headquartered in Shanghai and maintains a presence in the healthcare industry through its core activities.

Fosun Pharmaceutical offers Pharmaceuticals and Medical Devices.

Yes, Fosun Pharmaceutical is publicly traded on SSE under the ticker symbol 600196.

Fosun Pharmaceutical has made 3 acquisitions, including Antejin Biotech, Breas Medical, and Yiyanyun Medical Technology.

Fosun Pharmaceutical operates through Shanghai Fuxing Medicine (Group) Shareholding Company Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available